Corcept Therapeutics President, Oncology Roberto Wandenkolk Vieira Reports Sale of Common Shares Worth $674,068.7958

PUBT · 2d ago
Corcept Therapeutics President, Oncology Roberto Wandenkolk Vieira Reports Sale of Common Shares Worth $674,068.7958
  • Corcept Therapeutics President, Oncology, Roberto Wandenkolk Vieira sold 8,333 common shares on Nov. 2, 2026.
  • Sales comprised 6,657 shares at $80.7326 per share and 1,676 shares at $81.5226 per share.
  • Vieira also exercised stock options for 8,333 common shares at $21.63 per share.
  • The Nov. 4, 2026, filing reported remaining direct holdings of 3,946 common shares and 125,001 stock options.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-447899), on November 04, 2026, and is solely responsible for the information contained therein.